| Literature DB >> 23554708 |
Qinqin Pan1, Su Fan, Xiaoyan Wang, Xing Zhao, Meng Pan, Chengya Wang, Jie Shen.
Abstract
The present study was aimed to analyze the frequencies of human leukocyte antigen (HLA)-A, -B, and -DRB1 alleles and A-B-DRB1, A-B, A-DRB1 and B-DRB1 haplotypes in inhabitants of Guizhou province, China. All samples were typed in the HLA-A,-B, and -DRB1 loci using the polymerase chain reaction-reverse sequence specific oligonucleotide probe (PCR-rSSOP) method and HLA polymorphisms were analyzed. A total of 18 HLA-A, 31 HLA-B, and 13 HLA-DRB1 alleles were found in the Guizhou population. The first two frequent alleles in the HLA-A, -B, and -DRB1 loci were A*11(30.72%) and A*02(30.65%), B*40(16.27%) and B*46(16.27%), and DRB1*09(15.91%) and DRB1*15(13.51%), respectively. The most common haplotype was A*02-B*46-DRB1*09(5.59%) in A-B-DRB1, A*02-B*46(11.73%) in A-B, B*46-DRB1*09(7.49%) in B-DRB1, and A*02-DRB1*09(8.08%) in A-DRB1. Some haplotypes with strong linkage disequilibrium (LD) were found not only in the common haplotypes, such as A*33-B*58, B*30-DRB1*07, and B*33-DRB1*03, but also in the rare haplotypes, such as A*01-B*37, B*37-DRB1*10, and A*01-DRB1*10. Guizhou inhabitants shared some characteristics of the Southern Chinese population but also had their own unique features. Overall, HLA polymorphism in Guizhou population was more consistent with that of Chengdu population than that of other populations in China.Entities:
Keywords: Guizhou; allele; disequilibrium; haplotype; human leukocyte antigen; linkage
Year: 2011 PMID: 23554708 PMCID: PMC3596729 DOI: 10.1016/S1674-8301(11)60044-4
Source DB: PubMed Journal: J Biomed Res ISSN: 1674-8301
The Hardy-Weinberg equilibrium of HLA-A, -B, and -DRB1 loci in Guizhou population
| Locus | Genot | bs.Heter. | Exp.Heter. | SD | |
| 2,879 | 0.774 | 0.774 | 0.131 | 0.001 | |
| 2,879 | 0.911 | 0.903 | 0.263 | 0.000 | |
| 2,879 | 0.898 | 0.900 | 0.699 | 0.001 |
Frequencies of HLA-A, -B, and DRB1 alleles in Guizhou population
| Allele group | Allele frequency (%) | Allele group | Allele frequency (%) | Allele group | Allele frequency(%) |
| B*14 | 0.07 | B*58 | 6.32 | ||
| A*01 | 1.98 | B*15 | 13.89 | B*59 | 0.02 |
| A*02 | 30.65 | B*18 | 0.59 | B*67 | 0.50 |
| A*03 | 1.72 | B*27 | 1.77 | B*81 | 0.03 |
| A*11 | 30.72 | B*35 | 4.18 | Blank | 0.06 |
| A*23 | 0.19 | B*37 | 0.88 | ||
| A*24 | 17.07 | B*38 | 3.30 | DRB1*01 | 2.17 |
| A*25 | 0.02 | B*39 | 2.10 | DRB1*03 | 5.03 |
| A*26 | 2.29 | B*40 | 16.27 | DRB1*04 | 10.44 |
| A*29 | 0.75 | B*41 | 0.05 | DRB1*07 | 5.14 |
| A*30 | 3.26 | B*44 | 1.80 | DRB1*08 | 7.29 |
| A*31 | 2.67 | B*45 | 0.03 | DRB1*09 | 15.91 |
| A*32 | 0.55 | B*46 | 16.27 | DRB1*10 | 1.59 |
| A*33 | 7.43 | B*47 | 0.03 | DRB1*11 | 5.95 |
| A*34 | 0.06 | B*48 | 1.78 | DRB1*12 | 13.06 |
| A*36 | 0.02 | B*49 | 0.10 | DRB1*13 | 5.69 |
| A*68 | 0.46 | B*50 | 0.35 | DRB1*14 | 9.34 |
| A*69 | 0.07 | B*51 | 6.34 | DRB1*15 | 13.51 |
| A*74 | 0.05 | B*52 | 2.01 | DRB1*16 | 4.84 |
| Blank | 0.04 | B*53 | 0.02 | Blank | 0.04 |
| B*54 | 2.57 | ||||
| B*07 | 2.47 | B*55 | 3.96 | ||
| B*08 | 0.90 | B*56 | 0.90 | ||
| B*13 | 9.66 | B*57 | 0.78 |
(N = 2,879×2)
Distribution of HLA-A, -B, and -DRB1 genes
| Frequency range (%) | ||||||
| Cumulative frequency | Cumulative frequency | Cumulative frequency | ||||
| Total number | 18 | 99.96% | 31 | 99.94% | 13 | 99.96% |
| > 10% | 3 | 78.44% | 3 | 46.43% | 4 | 52.92% |
| 1%-10% | 6 | 19.35% | 13 | 48.26% | 9 | 47.04% |
| 0.1%-1% | 4 | 1.95% | 8 | 5.00% | 0 | 0 |
| < 0.1% | 5 | 0.22% | 7 | 0.25% | 0 | 0 |
Common haplotypes in Guizhou population occurring at a frequency over 1%
| ML-HF (%) | ML-HF (%) | ML-HF (%) | ML-HF (%) | ||||
| 02XX 46XX 09XX | 5.59 | 02XX 46XX | 11.73 | 46XX 09XX | 7.49 | 02XX 09XX | 8.08 |
| 33XX 58XX 03XX | 2.80 | 11XX 15XX | 6.89 | 15XX 12XX | 3.82 | 11XX 12XX | 6.07 |
| 30XX 13XX07XX | 2.23 | 11XX40XX | 6.19 | 58XX 03XX | 3.47 | 11XX 15XX | 5.68 |
| 02XX 46XX 14XX | 2.10 | 33XX 58XX | 5.10 | 46XX 14XX | 2.94 | 11XX 04XX | 3.57 |
| 11XX 15XX 15XX | 1.58 | 24XX 40XX | 5.01 | 15XX 15XX | 2.93 | 02XX 12XX | 3.57 |
| 02XX 46XX 08XX | 1.47 | 11XX 13XX | 3.92 | 15XX 04XX | 2.88 | 02XX 15XX | 3.53 |
| 33XX 58XX 13XX | 1.40 | 02XX 40XX | 3.48 | 13XX 07XX | 2.85 | 02XX 04XX | 3.08 |
| 11XX 15XX 04XX | 1.35 | 02XX 15XX | 3.18 | 13XX 15XX | 2.76 | 33XX 03XX | 2.85 |
| 11XX 46XX 09XX | 1.27 | 11XX46XX | 2.80 | 40XX 12XX | 2.51 | 02XX 08XX | 2.76 |
| 11XX 40XX 12XX | 1.22 | 30XX 13XX | 2.78 | 40XX 15XX | 2.45 | 02XX 14XX | 2.53 |
| 11XX 40XX 08XX | 1.16 | 24XX 15XX | 2.73 | 40XX 09XX | 2.30 | 24XX 09XX | 2.51 |
| 24XX 40XX 15XX | 1.00 | 02XX 38XX | 2.04 | 40XX 08XX | 2.16 | 11XX 08XX | 2.51 |
| 11XX51XX | 1.98 | 46XX 08XX | 2.09 | 24XX 15XX | 2.48 | ||
| 02XX 13XX | 1.94 | 40XX 11XX | 1.93 | 24XX 12XX | 2.47 | ||
| 02XX 51XX | 1.67 | 58XX 13XX | 1.77 | 11XX 09XX | 2.46 | ||
| 11XX55XX | 1.52 | 40XX 04XX | 1.67 | 11XX 14XX | 2.36 | ||
| 02XX 55XX | 1.40 | 15XX 09XX | 1.56 | 30XX 07XX | 2.30 | ||
| 24XX 51XX | 1.39 | 13XX 12XX | 1.54 | 24XX 14XX | 2.25 | ||
| 24XX 35XX | 1.17 | 51XX 09XX | 1.41 | 24XX 04XX | 2.19 | ||
| 24XX 46XX | 1.13 | 51XX 14XX | 1.27 | 02XX 16XX | 2.03 | ||
| 11XX39XX | 1.10 | 40XX 16XX | 1.17 | 11XX 11XX | 1.80 | ||
| 24XX 54XX | 1.07 | 40XX 14XX | 1.16 | 02XX 11XX | 1.73 | ||
| 46XX 12XX | 1.07 | 11XX 13XX | 1.66 | ||||
| 33XX 13XX | 1.66 | ||||||
| 11XX 16XX | 1.53 | ||||||
| 24XX 11XX | 1.24 | ||||||
| 24XX 08XX | 1.20 |
ML-HF: Maximum-likehood haplotype frequencies.
The relative strongest linkage equilibrium between HLA-A and -B
| Haplotype | Observed frequencies (%) | Expected frequencies (%) | D | D′ | r2 | chi-square |
| A*33-B*58 | 5.10 | 0.47 | 0.046 | 0.794 | 0.530 | 3043.778 |
| A*01-B*37 | 0.68 | 0.02 | 0.007 | 0.760 | 0.256 | 1468.645 |
| A*29-B*07 | 0.64 | 0.02 | 0.006 | 0.857 | 0.217 | 1246.909 |
| A*30-B*13 | 2.78 | 0.32 | 0.024 | 0.823 | 0.214 | 1230.311 |
| A*02-B*46 | 11.73 | 4.99 | 0.075 | 0.660 | 0.192 | 1101.331 |
| A*01-B*57 | 0.51 | 0.02 | 0.005 | 0.637 | 0.158 | 910.244 |
| A*23-B*49 | 0.05 | 0 | 0.001 | 0.499 | 0.136 | 780.135 |
| A*23-B*45 | 0.17 | 0 | 0 | 0.499 | 0.045 | 259.864 |
| A*24-B*40 | 5.01 | 2.77 | 0.027 | 0.198 | 0.037 | 213.080 |
| A*23-B*41 | 0.02 | 0 | 0 | 0.332 | 0.030 | 172.608 |
| A*11-B*15 | 6.89 | 4.26 | 0.027 | 0.280 | 0.029 | 164.227 |
| A*32-B*44 | 0.16 | 0.55 | 0.002 | 0.300 | 0.027 | 156.994 |
| A*02-B*58 | 0.23 | 1.93 | 0.017 | -0.892 | 0.024 | 135.708 |
| A*11-B*46 | 2.80 | 5.00 | -0.026 | -0.513 | 0.023 | 130.330 |
| A*36-B*57 | 0.02 | 0 | 0 | 1.000 | 0.022 | 0.008 |
| A*33-B*44 | 0.66 | 0.13 | 0.005 | 0.304 | 0.021 | 122.448 |
| A*02-B*38 | 2.04 | 1.01 | 0.011 | 0.504 | 0.020 | 112.472 |
| A*03-B*44 | 0.29 | 0.03 | 0.002 | 0.146 | 0.020 | 116.798 |
The relative strongest linkage equilibrium between HLA-B and -DRB1
| Haplotype | Observed frequencies (%) | Expected frequencies (%) | D | D′ | r2 | chi-square |
| B*37-DRB1*10 | 0.76 | 0.01 | 0.010 | 0.860 | 0.410 | 2342.480 |
| B*58-DRB1*03 | 3.46 | 0.32 | 0.030 | 0.670 | 0.360 | 2040.560 |
| B*46-DRB1*09 | 7.49 | 2.59 | 0.050 | 0.400 | 0.150 | 877.110 |
| B*13-DRB1*07 | 2.85 | 0.50 | 0.020 | 0.520 | 0.140 | 791.810 |
| B*07-DRB1*01 | 0.84 | 0.05 | 0.010 | 0.390 | 0.130 | 766.340 |
| B*08-DRB1*03 | 0.76 | 0.05 | 0.010 | 0.840 | 0.120 | 696.090 |
| B*57-DRB1*07 | 0.53 | 0.04 | 0 | 0.670 | 0.070 | 377.250 |
| B*58-DRB1*13 | 1.77 | 0.36 | 0.010 | 0.260 | 0.060 | 356.830 |
| B*15-DRB1*12 | 3.82 | 1.81 | 0.020 | 0.200 | 0.040 | 207.150 |
| B*07-DRB1*10 | 0.45 | 0.04 | 0 | 0.250 | 0.040 | 234.870 |
| B*15-DRB1*04 | 2.88 | 1.45 | 0.020 | 0.190 | 0.030 | 154.070 |
| B*13-DRB1*15 | 2.76 | 1.31 | 0.020 | 0.190 | 0.030 | 146.350 |
The first three frequent alleles in HLA-A,-B, and -DRB1 loci in Guizhou province and other populations in China
| Allel | Guizhou | Shanxi | Henan | Jiangsu | Hunan | Hainan |
| A*11 | 30.72 | 17.93 | 16.66 | 18.56 | 20.88 | 18.35 |
| A*02 | 30.65 | 29.26 | 29.09 | 29.55 | 19.64 | 15.45 |
| A*24 | 17.07 | 16.12 | 15.70 | 16.79 | 12.01 | 11.03 |
| B*40 | 16.27 | 12.98 | 13.15 | 13.58 | 15.31 | 10.78 |
| B*46 | 16.27 | 7.15 | 6.24 | 9.41 | 11.86 | 7.55 |
| B*15 | 13.89 | 13.84 | 13.70 | 14.40 | 9.54 | 8.55 |
| DRB1*09 | 15.91 | 12.85 | 13.02 | 16.15 | 13.01 | 7.56 |
| DRB1*15 | 13.51 | 16.77 | 17.86 | 13.09 | 9.55 | 9.50 |
| DRB1*12 | 13.06 | 10.67 | 9.95 | 12.22 | 8.89 | 8.25 |
(%)
The relative strongest linkage equilibrium between HLA-A and -DRB1
| Haplotype | Observed frequencies (%) | Expected frequencies (%) | D | D′ | r2 | chi-square |
| A*30-DRB1*07 | 2.30 | 0.17 | 0 | 0.697 | 0.303 | 1739.976 |
| A*33-DRB1*03 | 2.85 | 0.37 | 0.025 | 0.537 | 0.190 | 1094.590 |
| A*29-DRB1*10 | 0.38 | 0.01 | 0.040 | 0.504 | 0.118 | 675.721 |
| A*01-DRB1*10 | 0.58 | 0.03 | 0.006 | 0.357 | 0.102 | 588.272 |
| A*02-DRB1*09 | 8.08 | 4.87 | 0.038 | 0.349 | 0.052 | 298.950 |
| A*33-DRB1*13 | 1.67 | 0.42 | 0.013 | 0.537 | 0.049 | 279.805 |
| A*11-DRB1*12 | 6.07 | 4.00 | 0.025 | 0.276 | 0.026 | 147.557 |
| A*02-DRB1*03 | 0.36 | 1.54 | 0.012 | -0.808 | 0.015 | 87.747 |
| A*11-DRB1*15 | 5.68 | 4.16 | 0.018 | 0.191 | 0.013 | 74.271 |
| A*11-DRB1*07 | 0.38 | 1.58 | 0.012 | -0.736 | 0.013 | 74.900 |
| A*02-DRB1*13 | 0.56 | 1.74 | -0.010 | -0.600 | 0.010 | 54.862 |